News

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...
M-Strip, the self-sampling kit for cervical cancer (HPV) and STI screening, provides a non-invasive alternative to ...
Almost all cases are caused by human papillomavirus (HPV) infection, with approximately 80% classified as squamous cell carcinoma (SCC); the remainder are largely adenocarcinomas. Cervical cancer ...
Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and neck squamous cell carcinoma (HNSCC). The research reveals how ENO2 and its ...
An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...
"I had cancer," she detailed, "cervical cancer ... Then in 2017, Camille had surgery to remove Squamous Cell Carcinoma, a type of skin cancer. TV host reveals he underwent surgery for ...
Most had an ECOG performance score of 0, and most had FIGO (2009) stage IB1 (56%) and IB2 (34%) disease, along with squamous cell ... early-stage high-risk cervical cancer that collected PRO ...
A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma ...
CLEVELAND — Fenofibrate, patented in 1969 and in medical use since 1975, is well-established as a cholesterol-lowering treatment. However, University Hospitals scientists believe it may also ...
Key Highlights: <li /> Global first immuno + anti-vascular bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC.
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck CancerConference call and webcast today ...